The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity

University of Pennsylvania

Status and phase: Terminated; Phase 4

Conditions: Cesarean Section

Treatments: Drug: Timing of prophylactic antibiotic administration

Study type: Interventional

Funder types: Other

Identifiers

NCT00133029

705719

Details and patient eligibility

About

The purpose of this study is to determine whether the timing of prophylactic antibiotic administration for cesarean section (immediate preoperative versus intraoperative administration) impacts the rate of postoperative febrile morbidity. The specific aim of the project is to test the hypothesis that preoperative antibiotic administration will decrease the rate of composite postoperative febrile morbidity.

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Gestational age > 36 weeks
• Ability to understand requirements of the study
• Elective/non-emergent cesarean section selected as route of delivery by treating physicians

Exclusion criteria

• Known fetal anomaly
• Exposure to antibiotics within 7 days of admission, including intrapartum group B streptococcal (GBS) prophylaxis
• Emergent cesarean delivery (i.e. for fetal distress, maternal distress, obstetric hemorrhage)
• Overt maternal intrapartum infection requiring antibiotics
• Prolonged rupture of membranes (>18 hours)